136 related articles for article (PubMed ID: 22223052)
1. Identification of influenza virus inhibitors targeting NS1A utilizing fluorescence polarization-based high-throughput assay.
Cho EJ; Xia S; Ma LC; Robertus J; Krug RM; Anslyn EV; Montelione GT; Ellington AD
J Biomol Screen; 2012 Apr; 17(4):448-59. PubMed ID: 22223052
[TBL] [Abstract][Full Text] [Related]
2. The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target.
Twu KY; Noah DL; Rao P; Kuo RL; Krug RM
J Virol; 2006 Apr; 80(8):3957-65. PubMed ID: 16571812
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel influenza inhibitors targeting the interaction of dsRNA with the NS1 protein by structure-based virtual screening.
Ai H; Zheng F; Zhu C; Sun T; Zhang L; Liu X; Li X; Zhu G; Liu H
Int J Bioinform Res Appl; 2010; 6(5):449-60. PubMed ID: 21224203
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence polarization-based assay using N-glycan-conjugated quantum dots for screening in hemagglutinin blockers for influenza A viruses.
Okamatsu M; Feng F; Ohyanagi T; Nagahori N; Someya K; Sakoda Y; Miura N; Nishimura S; Kida H
J Virol Methods; 2013 Feb; 187(2):390-4. PubMed ID: 23164994
[TBL] [Abstract][Full Text] [Related]
5. Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode.
Chien CY; Xu Y; Xiao R; Aramini JM; Sahasrabudhe PV; Krug RM; Montelione GT
Biochemistry; 2004 Feb; 43(7):1950-62. PubMed ID: 14967035
[TBL] [Abstract][Full Text] [Related]
6. Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.
Baughman BM; Jake Slavish P; DuBois RM; Boyd VA; White SW; Webb TR
ACS Chem Biol; 2012 Mar; 7(3):526-34. PubMed ID: 22211528
[TBL] [Abstract][Full Text] [Related]
7. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA.
Li S; Min JY; Krug RM; Sen GC
Virology; 2006 May; 349(1):13-21. PubMed ID: 16466763
[TBL] [Abstract][Full Text] [Related]
8. Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses.
Yin C; Khan JA; Swapna GV; Ertekin A; Krug RM; Tong L; Montelione GT
J Biol Chem; 2007 Jul; 282(28):20584-92. PubMed ID: 17475623
[TBL] [Abstract][Full Text] [Related]
9. Optimizations of a novel fluorescence polarization-based high-throughput screening assay for β-catenin/LEF1 interaction inhibitors.
Chen Y; Fu Z; Li D; Yue Y; Liu X
Anal Biochem; 2021 Jan; 612():113966. PubMed ID: 32956692
[TBL] [Abstract][Full Text] [Related]
10. Virtual screening of potential inhibitors from TCM for the CPSF30 binding site on the NS1A protein of influenza A virus.
Ai H; Zhang L; Chang AK; Wei H; Che Y; Liu H
J Mol Model; 2014 Mar; 20(3):2142. PubMed ID: 24562912
[TBL] [Abstract][Full Text] [Related]
11. Exploring the molecular basis of dsRNA recognition by NS1 protein of influenza A virus using molecular dynamics simulation and free energy calculation.
Pan D; Sun H; Shen Y; Liu H; Yao X
Antiviral Res; 2011 Dec; 92(3):424-33. PubMed ID: 22001595
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for dsRNA recognition by NS1 protein of influenza A virus.
Cheng A; Wong SM; Yuan YA
Cell Res; 2009 Feb; 19(2):187-95. PubMed ID: 18813227
[TBL] [Abstract][Full Text] [Related]
13. Development of a high-throughput fluorescence polarization assay to identify novel ligands of glutamate carboxypeptidase II.
Alquicer G; Sedlák D; Byun Y; Pavlícek J; Stathis M; Rojas C; Slusher B; Pomper MG; Bartunek P; Barinka C
J Biomol Screen; 2012 Sep; 17(8):1030-40. PubMed ID: 22751730
[TBL] [Abstract][Full Text] [Related]
14. Dimer interface of the effector domain of non-structural protein 1 from influenza A virus: an interface with multiple functions.
Aramini JM; Ma LC; Zhou L; Schauder CM; Hamilton K; Amer BR; Mack TR; Lee HW; Ciccosanti CT; Zhao L; Xiao R; Krug RM; Montelione GT
J Biol Chem; 2011 Jul; 286(29):26050-60. PubMed ID: 21622573
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors.
You L; Cho EJ; Leavitt J; Ma LC; Montelione GT; Anslyn EV; Krug RM; Ellington A; Robertus JD
Bioorg Med Chem Lett; 2011 May; 21(10):3007-11. PubMed ID: 21478016
[TBL] [Abstract][Full Text] [Related]
16. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS.
Noah DL; Twu KY; Krug RM
Virology; 2003 Mar; 307(2):386-95. PubMed ID: 12667806
[TBL] [Abstract][Full Text] [Related]
17. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
[TBL] [Abstract][Full Text] [Related]
18. Development of a High-Throughput Fluorescence Polarization Assay to Detect Inhibitors of the FAK-Paxillin Interaction.
Marlowe T; Alvarado C; Rivera A; Lenzo F; Nott R; Bondugji D; Montoya J; Hurley A; Kaplan M; Capaldi A; Cance W
SLAS Discov; 2020 Jan; 25(1):21-32. PubMed ID: 31513463
[TBL] [Abstract][Full Text] [Related]
19. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
Oh KS; Lee S; Lee BH
Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
[TBL] [Abstract][Full Text] [Related]
20. Development of a high-throughput fluorescence polarization assay for the discovery of phosphopantetheinyl transferase inhibitors.
Duckworth BP; Aldrich CC
Anal Biochem; 2010 Aug; 403(1-2):13-9. PubMed ID: 20382102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
